Butler John P.
CEO and President at AKBA; Director at Zynerba Pharmaceuticals, Inc.; Director at Relypsa Inc
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Feb 2, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- AKBAAkebia Therapeutics, Inc.CEO and President
- Zynerba Pharmaceuticals, Inc.Director
- Relypsa IncDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- AKBA926,381 shares
- Relypsa Inc2,113 shares
- Zynerba Pharmaceuticals, Inc.168 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AKBANo planFeb 27, 2024 2024
Sold 37,733 shares at $1.52 ($57k)
Butler John P., CEO and President
No 10b5-1 planSold 1.8% of holdings ($3.2M position)2.1M shares left0.6x usual sizeFollows a Form 144Filing
- 2 Form 144 notice AKBANoticeFeb 29, 2024 +2 days
Filed to sell 46,570 shares ($73k)
Butler John P., Officer, Director
No 10b5-1 plan1x usual sizeFiling
- 3 Form 4 sale AKBANo planFeb 29, 2024 same day
Sold 46,570 shares at $1.58 ($74k)
Butler John P., CEO and President
No 10b5-1 planSold 2.2% of holdings ($3.3M position)2M shares left1.1x usual sizeFollows a Form 144Filing
- 4 Form 144 notice AKBANoticeFeb 3, 2025 +340 days
Filed to sell 144,250 shares ($304k)
Butler John P., Officer, Director
No 10b5-1 plan3.1x usual sizeFiling
- 5 Form 4 sale AKBAUnusualFeb 3, 2025 same day
Sold 144,250 shares at $2.10 ($303k)
Butler John P., CEO and President
10b5-1 planSold 5.2% of holdings ($5.8M position)2.6M shares left3.1x usual sizeFollows a Form 144Filing
- 6 Form 144 notice AKBANoticeMar 3, 2025 +28 days
Filed to sell 46,409 shares ($85k)
Butler John P., Officer, Director
No 10b5-1 plan1x usual sizeFiling
- 7 Form 4 sale AKBARoutineMar 3, 2025 same day
Sold 46,409 shares at $1.83 ($85k)
Butler John P., CEO and President
10b5-1 planSold 1.8% of holdings ($4.8M position)2.6M shares left1x usual sizeFollows a Form 144Filing
- 8 Form 4 sale AKBAUnusualFeb 2, 2026 +336 days
Sold 341,305 shares at $1.39 ($474k)
Butler John P., CEO and President
10b5-1 planSold 9.4% of holdings ($5.1M position)3.3M shares left7.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (20)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 4, 2026 | AKBA | CEO and President | Form 4 sale | 341,305 | $474k | 9.4% | Unusual | SEC |
| Mar 3, 2025 | Mar 4, 2025 | AKBA | CEO and President | Form 4 sale | 46,409 | $85k | 1.8% | Routine | SEC |
| Mar 3, 2025 | Mar 3, 2025 | AKBA | Officer, Director | Form 144 notice | 46,409 | $85k | Notice | SEC | |
| Feb 3, 2025 | Feb 4, 2025 | AKBA | CEO and President | Form 4 sale | 144,250 | $303k | 5.2% | Unusual | SEC |
| Feb 3, 2025 | Feb 3, 2025 | AKBA | Officer, Director | Form 144 notice | 144,250 | $304k | Notice | SEC | |
| Feb 29, 2024 | Mar 1, 2024 | AKBA | CEO and President | Form 4 sale | 46,570 | $74k | 2.2% | No plan | SEC |
| Feb 29, 2024 | Feb 29, 2024 | AKBA | Officer, Director | Form 144 notice | 46,570 | $73k | Notice | SEC | |
| Feb 27, 2024 | Feb 29, 2024 | AKBA | CEO and President | Form 4 sale | 37,733 | $57k | 1.8% | No plan | SEC |
| Feb 27, 2024 | Feb 27, 2024 | AKBA | Officer, Director | Form 144 notice | 37,733 | $57k | Notice | SEC | |
| Feb 1, 2024 | Feb 2, 2024 | AKBA | CEO and President | Form 4 sale | 46,489 | $78k | 2.1% | No plan | SEC |
| Feb 1, 2024 | Feb 1, 2024 | AKBA | Officer, Director | Form 144 notice | 46,489 | $78k | Notice | SEC | |
| Jun 14, 2023 | Jun 15, 2023 | Zynerba Pharmaceuticals, Inc. | Director | Form 4 sale | 115 | $40 | 0.1% | No plan | SEC |
| Mar 1, 2023 | Mar 3, 2023 | AKBA | CEO and President | Form 4 sale | 91,868 | $81k | 5.5% | Plan not stated | SEC |
| Feb 27, 2023 | Mar 1, 2023 | AKBA | CEO and President | Form 4 sale | 38,632 | $31k | 2.3% | Plan not stated | SEC |
| Jun 14, 2022 | Jun 16, 2022 | Zynerba Pharmaceuticals, Inc. | Director | Form 4 sale | 53 | $54 | 0.2% | Plan not stated | SEC |
| Mar 1, 2022 | Mar 2, 2022 | AKBA | CEO and President | Form 4 sale | 79,026 | $171k | 5.3% | Plan not stated | SEC |
| Apr 1, 2021 | Apr 1, 2021 | AKBA | CEO and President | Form 4 sale | 4,109 | $14k | 0.4% | Plan not stated | SEC |
| Mar 1, 2021 | Mar 2, 2021 | AKBA | CEO and President | Form 4 sale | 49,990 | $170k | 4.3% | Plan not stated | SEC |
| Jun 7, 2016 | Jun 8, 2016 | Relypsa Inc | Director | Form 4 sale | 1,013 | $20k | 26.2% | Unusual | SEC |
| Jun 11, 2015 | Jun 15, 2015 | Relypsa Inc | Director | Form 4 sale | 1,100 | $38k | 22.2% | Plan not stated | SEC |